Tenderwize
Wróć do wyszukiwania

Open house Doravirin discount agreements

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Apr 03, 2028 · 584 days left·Open·Supplies·Framework
Zarejestruj się, aby zapisaćOpen documents
Structured notice only
Oryginalny tytuł ogłoszenia

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Doravirin, ATC J05AG06

50/100

Ocena szansy

Needs reviewLow complexity
SuppliesFrameworkOpen
Skąd ta ocena?

Szansa

50 / 100

Złożoność

20 / 100

Czynniki ryzyka

No estimated value or framework maximum value is provided. The commercial opportunity cannot be quantified.

Open-house agreements automatically expire if a traditional procurement discount contract (federal or state level) is s...

Głęboka analiza portfolio

Głęboka analiza dopasowania firmy

Wykorzystuje:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Przegląd

Moderate opportunity

Kluczowe fakty

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until May 2028
  • Supply of Doravirin (ATC J05AG06) pharmaceutical products
  • Non-exclusive discount agreements with AOK Bayern
Pokaż pełne podsumowanie

Open-house model (non-exclusive) for discount agreements on the active substance Doravirin (ATC J05AG06) with AOK Bayern. All eligible pharmaceutical companies can join identical, non-negotiable contracts for the period 01.06.2026 to 31.05.2028. No estimated value provided. No formal award criteria since no selection takes place. Submission via signed declaration of reliability; physical or electronic with qualified signature accepted. Contracts can be concluded at any time until 03.04.2028.

Ryzyka

No estimated value or framework maximum value is provided. The commercial opportunity cannot be quantified.

Open-house agreements automatically expire if a traditional procurement discount contract (federal or state level) is s...

Analiza może być niepełna

Przeanalizowano tylko część dokumentacji. Pozostałe dokumenty mogą zawierać dodatkowe wymagania, certyfikaty lub dokumenty do złożenia.

Kluczowe wymagania

Certifications

  • Eligibility: signed declaration of reliability (self-certification form)
  • Language: documents must be in German or accompanied by a certified German translation

Administrative

  • Submission: physical (2 copies original, hand-signed) or electronic (qualified electronic signature) via DTVP portal

Wymagania mogą być niepełne.

Kryteria udzielenia

Lot 1

No award criteria – open-house model, no selection among participants.

Zamawiający

Lokalizacja

München, DEU

Profil zamawiającego

Otwórz profil

Identyfikator

DE811695320

Działalność

Health

Części (1)

LOT-0001

Open house Doravirin discount agreements

Non-exclusive discount agreements for Doravirin (ATC J05AG06) with AOK Bayern. Contracts run from 01.06.2026 to 31.05.2028. Open to all pharmaceutical companies meeting eligibility. No selection – all who apply and meet criteria get a contract. Submission deadline: contracts can be signed until 03.04.2028 (monthly cut-off dates apply for start dates).

SuppliesFrameworkEU fundedElectronic submission

Lokalizacja

DE212, Germany

Czas trwania

May 2026 - May 2028

Kategoria

Pharmaceutical products

Kryteria udzielenia

No award criteria – open-house model, no selection among participants.

Termin

Deadline Apr 03, 2028

Szczegóły zamówienia

Data publikacji
14 Apr 2026
Języki
German

Metadane referencyjne

Podstawa prawna
32014L0024

Identyfikatory referencyjne

ID przetargu
257844-2026

Dokumenty (2)

Dokument zamówienia 1Portal składania ofert 1

Podobne przetargi

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 27 - Follitropin delta

Aug 30